SOC + BSB-1001 Dose Escalation Cohort

TERMINATED · PHASE1, PHASE2 · AML, Adult Recurrent, ALL, Recurrent, Adult, MDS

Company Decision

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.